Insiders · Profile

Dubovsky Filip

President, R&D at NOVAVAX. Filing since 14 May 2024. CIK 0001977361

Company

Date

Role

Action

Shares

Amount

Of holding

NVAX NOVAVAX INC

17 Jun 2024

President, R&D

Sold at will

13,904

$201.16K

17.3%

NVAX NOVAVAX INC

14 May 2024

President, R&D

Sold at will

47,312

$657.64K

54.8%

2 decisions on file.